sellWeak cluster of 410b5-1 plan
Bhavesh Ashar sold $62k of SWTX
Chief Commercial Officer at SpringWorks Therapeutics, Inc.. 1,016 shares at an average of $61.19, traded Feb 20, 2025, filed Feb 24, 2025.
Warning score
17Value
$62k
1,016 shares
Holdings after
62,053
-2% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- +7Trade size$62k at market
- 0Share of holdings soldSold 1.6% of holdings
- +15Cluster4 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001104659-25-016615, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 20, 2025 | SOpen-market sale Common Stock10b5-1 | -1,016 | $61.19 | $62k | 62,053 | Feb 24, 2025 |
Related signals
Other insiders at SpringWorks Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 45Moderate | SpringWorks Therapeutics, Inc. | Badreddin Edris Chief Operating Officer | $1.1M 20,000 shares | -11% | |
| 45Moderate | SpringWorks Therapeutics, Inc. | Saqib Islam Chief Executive Officer | $2.7M 49,000 shares | -5% | |
| 45Moderate | SpringWorks Therapeutics, Inc. | Saqib Islam Chief Executive Officer | $1.8M 29,328 shares | -3% | |
| 40Moderate | SpringWorks Therapeutics, Inc. | Saqib Islam Chief Executive Officer | $639k 10,672 shares | -1% | |
| 45Moderate | SpringWorks Therapeutics, Inc. | Badreddin Edris Chief Operating Officer | $1.6M 30,000 shares | -14% | |
| 36Weak | SpringWorks Therapeutics, Inc. | Julie Hambleton director | $730k 13,774 shares | -77% | |
| 45Moderate | SpringWorks Therapeutics, Inc. | Saqib Islam Chief Executive Officer | $2.6M 48,000 shares | -5% | |
| 31Weak | SpringWorks Therapeutics, Inc. | Badreddin Edris Chief Operating Officer | $839k 20,000 shares | -9% | |
| 38Weak | SpringWorks Therapeutics, Inc. | Saqib Islam Chief Executive Officer | $2.0M 49,000 shares | -5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.